Kronisk inflammatorisk demyeliniserende polyneuropati

Translated title of the contribution: Chronic inflammatory demyelinating polyneuropathy

Lars Kjøbsted Markvardsen, Thomas Harbo, Jakob Vormstrup Holbech, Hatice Tankisi, Ingelise Christiansen, Niels Kjær Olsen, Johannes Jakobsen, Søren Hein Sindrup, Henning Andersen

Research output: Contribution to journalJournal articleResearchpeer-review


In this review, we discuss chronic inflammatory demyelinating polyneuropathy (CIDP), which is a disease with proximal and distal weakness and sensory disturbances resulting in impaired daily activity. The diagnosis is based on the clinical presentation and electrophysiology demonstrating demyelination in the peripheral nerves. CIDP can be successfully treated with immunoglobulin, glucocorticoids or plasma exchange, and during the latest decade, immunoglobulin has been administered subcutaneously improving patients’ flexibility and autonomy. By time, 30% of the patients will remit, and maintenance treatment will no longer be necessary.
Translated title of the contributionChronic inflammatory demyelinating polyneuropathy
Original languageDanish
Article numberV02190079
JournalUgeskrift for Læger
Issue number9
Publication statusPublished - 2020


Dive into the research topics of 'Chronic inflammatory demyelinating polyneuropathy'. Together they form a unique fingerprint.

Cite this